Results 101 to 110 of about 221,174 (192)

Meningococcal Vaccines: Challenges and Prospects. [PDF]

open access: yesVaccines (Basel), 2020
Bagwe P   +5 more
europepmc   +1 more source

Critical appraisal of a quadrivalent CRM197 conjugate vaccine against meningococcal serogroups A, C W-135 and Y (Menveo®) in the context of treatment and prevention of invasive disease

open access: yesInfection and Drug Resistance, 2011
Michael Bröker, Brian Cooper, Lisa M DeTora, Jeffrey J StoddardGlobal Medical Affairs, Novartis Vaccines and Diagnostics, Marburg, Germany, and Cambridge, MA, USAAbstract: Worldwide, invasive meningococcal disease affects about 500,000 people ...
Bröker M   +3 more
doaj  

Meningococcal vaccines and protein-energy undernutrition in children in the African meningitis belt. [PDF]

open access: yesVaccine, 2020
Sundaram ME   +6 more
europepmc   +1 more source

Economic evaluation of meningococcal vaccines: considerations for the future. [PDF]

open access: yesEur J Health Econ, 2020
Christensen H   +17 more
europepmc   +1 more source

Safety and immunogenicity of 4CMenB and MenACWY-CRM meningococcal vaccines when administered concomitantly in healthy adolescents: A phase 3b, randomized, observer-blind study. [PDF]

open access: yesHum Vaccin Immunother
Hoberman A   +11 more
europepmc   +1 more source

Meningococcal ACWY vaccines \ue2\u20ac\u201dMenACWY and MPSV4: what you need to know

open access: yes
Meningococcal disease is a serious illness caused by a type of bacteria called Neisseria meningitidis. It can lead to meningitis (infection of the lining of the brain and spinal cord) and infections of the blood.

core  

Home - About - Disclaimer - Privacy